Search

Author/Creator Shalabi, Ahmed

1. Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab. Issue 5 (7th January 2022)

Authors:
Miller, Charles; Kwok, Hanson; Harrow, Paul; Vega, Roser; Seward, Edward; Mehta, Shameer; Rahman, Farooq; McCartney, Sara; Parisi, Ioanna; Lim, Samuel Hsiang; Sharma, Esha; Samaan, Mark A; Bancil, Aaron; Kok, Klaartje Bel; Shalabi, Ahmed; Johnston, Emma L; Katarey, Dev; Taherzadeh, Nina; Murray, ...
Journal:
Frontline gastroenterology
Issue:
Volume 13:Issue 5(2022)
Page Start:
392
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Volumetric assessment of unaffected parenchyma and Wilms' tumours: analysis of response to chemotherapy and surgery using a semi‐automated segmentation algorithm in children with renal neoplasms. (27th February 2020)

Authors:
Rickard, Mandy; Fernandez, Nicolas; Blais, Anne‐Sophie; Shalabi, Ahmed; Amirabadi, Afsaneh; Traubici, Jeffrey; Lee, Wayne; Gleason, Joseph; Brzezinski, Jack; Lorenzo, Armando J.
Journal:
BJU international
Issue:
Volume 125:Number 5(2020)
Page Start:
695
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗